← SynDRA
GALLIC ACID
SynDRA canonical compound SYN0002081 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | CA1 |
|---|
| Mechanism of action | Beta amyloid inhibitor |
|---|
| Indication | internal deoderant |
|---|
| Disease area | gastroenterology |
|---|
All known targets
- CA1
- CA12
- CA14
- CA2
- CA4
- CA6
- CA9
- SELP
- APP
- F12
- NOS1
- PPARG
Mechanisms of action (all sources)
- PPAR receptor agonist
- Beta amyloid inhibitor
- F12 ACTIVATOR
- Coagulation factor XII activator
- CA1 INHIBITOR
- nitric oxide synthase inhibitor
- beta amyloid protein neurotoxicity inhibitor
- CA4 INHIBITOR
- CA14 INHIBITOR
- CA6 INHIBITOR
- SELP INHIBITOR
- CA9 INHIBITOR
Drug classes
- Anti-Infective Agents
- Coagulants
- Hematologic Agents
- Hemostatics
Cross-references
Synonyms
- bismuth subgallate
- bismuth gallate
- Benzoic acid, 3,4,5-trihydroxy-
- Gallate
- NSC-20103
- NSC-674319
- GALLICACID
- 3,4,5-Trihydroxybenzoic acid
- gallate
- Gallic acid, tech.
- GALOP
- Pyrogallol-5-carboxylic acid
- Kyselina gallova
- HSDB 2117
- 3,4,5-Trihydroxybenzoate
- CCRIS 5523
- Kyselina gallova [Czech]
- Gallic acid polymer
- UNII-632XD903SP
- NSC 674319
- Gallicum acidum
- CHEBI:30778
- AI3-16412
- Kyselina 3,4,5-trihydroxybenzoova
- EINECS 205-749-9
- NSC 20103
- BRN 2050274
- GALLIC ACID ANHYDROUS
- Kyselina 3,4,5-trihydroxybenzoova [Czech]
- CHEMBL288114
- LNTHITQWFMADLM-UHFFFAOYSA-N
- 632XD903SP
- gallic-acid
- NSC20103
- DTXCID60650
- Acid, Gallic
- Gallic Acid 1520
- RefChem:6437
Look up GALLIC ACID in the interactive SynDRA portal →